Author:
Chen Huiyan,Zhou Lin,Fong Daniel,Cun Yingli,Yang Zheng,Wan Chonghua
Abstract
Abstract
Background
Quality of life research can guide clinical workers to adopt more targeted treatment and intervention measures, so as to achieve the purpose of improving patients’ quality of life. The objective of this study was to evaluate health-related quality of life in Chinese patients with cervical cancer and to explore its influencing factors.
Methods
A total of 186 patients with cervical cancer were investigated by using the QLICP-CE (V2.0) scale (Quality of Life Instruments for Cancer Patients-Cervical Cancer) developed by our group in China. The data were analyzed by t-test, one-way ANOVA, univariate analysis, and multivariate linear regression.
Results
The total score of quality of life scale for cervical cancer patients was (62.58 ± 12.69), Univariate analysis of objective clinical indexes showed that creatinine concentration was a negative influence factor in the psychological domain, potassium ion concentration was a negative influence factor in the common symptoms and side effect domain, erythrocyte content was a positive influence factor physical domain and common general domain. Multiple linear regression results suggested that clinical staging was the influencing factor of common symptom and side effect domain, common general module and total score of scale. Marital status has different degrees of influence on the psychological, social, and common general domains. The level of education also influenced scores in the social domain.
Conclusion
The total score of quality of life in patients with cervical cancer who received active treatment was acceptable. Marital status, clinical staging, and educational level are the factors that affect the quality of life of patients with cervical cancer. At the same time, potassium ion concentration, red blood cell count and creatinine concentration also have important effects on quality of life in patients with cervical cancer. Therefore, it is very important to give personalized treatment and nursing to patients based on various factors.
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Tang M. Research progress on epidemiology and risk factors of cervical cancer. Cardiovasc Disease Electron J Integr Traditional Chin Western Med. 2017;5:18–9.
2. Huang J, Deng Y, Boakye D, Tin MS, Lok V, Zhang L, Lucero-Prisno DE 3rd, Xu W, Zheng ZJ, Elcarte E, Withers M, Wong MCS. Global distribution, risk factors, and recent trends for cervical cancer: a worldwide country-level analysis. Gynecol Oncol. 2022;164(1):85–92.
3. Bray F, Ferlay J, Soerjomataram I,Siegel RL, Torre LA,Jemal A. Global cancer statistics 2018: GLOB OCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer Clin. 2018;68:394–424.
4. Liu ZC, Li ZX, Zhang Y, Zhou T, Zhang JY, You WC,Pan KF, Li WQ. Interpretation of global cancer statistics report 2020. J Integr Oncol. 2021;7:1–14.
5. Cai HL, Yuan WG,Sun HX. Prevalence and prevention strategies of cervical cancer in the world and China. Chin Clin Oncol. 2023;28(01):90–3.